期刊文献+

CXCL16在db/db糖尿病肾病小鼠肾组织中的表达 被引量:3

Expression of CXCL16 in the kidney of diabetic db/db mice
下载PDF
导出
摘要 目的:了解在糖尿病肾病(DN)发生发展过程中,CXCL16在db/db小鼠肾脏中的表达变化,并对其与DN的相关性进行初步探讨。方法:选取分别代表DN不同发展阶段的4、8、12、16和20周龄的db/db小鼠和同龄db/m小鼠各6只;取左肾的一半用于提取总RNA;右肾用于制作冰冻切片、石蜡切片、电镜标本等;利用半定量RT-PCR的方法分析各组小鼠肾脏中CXCL16 mRNA相对表达水平,以免疫组化的方法分析CXCL16蛋白在各组小鼠肾组织中的表达和分布情况;同时测定各组小鼠的体重、血糖、血三酰甘油、血胆固醇和24h尿白蛋白排泄量,分析各组小鼠的肾脏组织病理情况以了解小鼠DN的发生发展情况。结果:(1)与同龄的db/m小鼠相比,4周龄的db/db小鼠的体重有所增加,但血糖、血三酰甘油、血胆固醇、24h尿白蛋白排泄量均无明显差异,肾脏组织病理分析也无明显变化,说明4周龄的db/db小鼠尚未发生糖尿病;但8周龄的db/db小鼠的血糖、24h尿白蛋白排泄量均已有明显升高,且肾组织中也已出现肾小球肥大、系膜区扩张、基膜增厚等DN病理改变,说明8周龄的db/db小鼠已发生了DN,但从各方面的情况来看,8周龄db/db小鼠的DN仍较轻,可代表DN早期的情况;自8周龄以后,db/db小鼠的血糖、血三酰甘油、血胆固醇、尿白蛋白排泄量以及肾小球肥大、系膜区扩张、基膜增厚等情况随着鼠龄的增长而不断的增加,说明db/db小鼠的DN不断进展。(2)与同龄的db/m小鼠相比,CXCL16在4周龄的db/db小鼠肾脏中的表达并没有明显变化;但8周龄db/db小鼠肾脏中CXCL16的表达水平已有所增加。此后,随着鼠龄的增加,DN的进展,CXCL16的表达水平逐渐增加。(3)在成年正常小鼠,CXCL16主要分布于小鼠肾脏髓质的小管中,相对来说在肾脏皮质中的分布较少;在DN小鼠,分布在肾小管和小球中的CXCL16均有明显增加;且肾小球CXCL16的表达增加主要发生在足细胞的位置。(4)CXCL16在幼年小鼠(指4周龄的db/m和db/db小鼠)肾脏中的表达分布与成年小鼠(指8周龄以上)亦存在一些差异,这可能提示CXCL16与小鼠肾脏的正常生长发育有关。结论:db/db小鼠肾脏中CXCL16的表达随DN的发生发展而增高,至少在时间上与DN具有相关性,提示CXCL16可能参与DN的病理过程。 Objective:To investigate the renal expression of CXCL16 in db/db mice, a model of type 2 diabetic nephropathy(DN), during the development of DN. Methodology:Kidney samples were obtained from db/db mice and their db/m littermates at the age of 4,8,12,16 and 20 weeks. The expression of CXCL16 was assessed by RT-PCR and immunohistocbemistty, and then correlated with biochemical and histological indices of kidney injury. Results: No significant difference of CXCL16 expression was found in the kidney of db/db mice as compared with the control db/m mice at the age of 4 weeks, a time when all biochemical and histological indices indicated that the db/db mice were in pre-diabetic condition. However, with the development of obesity, hyperglycemia and proteinuria, the expression of CXCL16 in the kidney of db/db mice increased. CXCL16 protein was distributed mainly in the renal distal tubule and in the glomerular podocytes to a less extent. Besides, different distribution of CXCL16 was also found between young mice(4-week-old db/m and db/db mice) and adult mice(db/m mice of 8-week-old and older than 8 weeks), which may suggest that CXCLI6 might have some thing to do with the growth and development of kidney. Conclusion: Renal CXCLI6 expression increased with the development of DN suggests that CXCL16 might involve in the initiation and development of DN in db/db mice.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2010年第3期236-240,247,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 CXCL16 糖尿病肾病 DB/DB小鼠 CXCL16 diabetic nephropathy db/db mice
  • 相关文献

参考文献16

  • 1Balakumar P,Arora MK,Ganti SS,et al.Recent advances in pharmacotherapy for diabetic nephropathy:current perspectives and future directions.Pharmacol Res,2009,60(1):24 -32.
  • 2陈建康,邹万忠,由江峰.内皮素与肾小球系膜细胞的关系[J].中华病理学杂志,1996,25(4):206-208. 被引量:26
  • 3郑敬民,刘志红,张鑫,黎磊石.db/db小鼠糖尿病肾病相关基因的分析和克隆[J].生物化学与生物物理进展,2003,30(3):406-411. 被引量:9
  • 4吴义超,刘志红,曾彩虹,苏健,陈朝红,黎磊石.糖尿病肾病患者肾小球基因表达谱及其与病情进展的关系[J].肾脏病与透析肾移植杂志,2004,13(6):503-511. 被引量:14
  • 5陈姗,刘志红,王瑞石,孙骅,陈丹,陈朝红,黎磊石.糖尿病肾病疾病进展相关基因的基因组学研究[J].中华肾脏病杂志,2006,22(9):528-534. 被引量:13
  • 6Sheikine Y,Sirsj(o) A.CXCL16/SR-PSOX-a friend or a foe in atherosclerosis? Atherosclerosis,2008,197 (2):487-495.
  • 7Oh ST,Schramme A,Tilgen W,et al.Overexpression of CXCL16 in lesional psoriatic skin.Dermatoendocrinol,2009,1 (2):114-118.
  • 8Schramme A,Abdel-Bakky MS,K(a)mpfer-Kolb N,et al.The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.Biochem Biophys Res Commun,2008,370(2):311 -316.
  • 9Schramme A,Abdel-Bakky MS,Gutwein P,et al.Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.Kidney Int,2008,74(3):328 -338.
  • 10Wu T,Xie C,Wang HW,et al.Elevated urinary VCAM-1,P-selectin,soluble TNF receptor-1,and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis.J Immunol,2007,179(10):7166 -7175.

二级参考文献72

  • 1刘志红,黎磊石.系统生物学——推动肾脏病临床研究的新动力[J].肾脏病与透析肾移植杂志,2005,14(1):1-3. 被引量:9
  • 2Matalon R, Rady P L, Platt K A, et al. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med, 2000, 2 (3): 165-175.
  • 3Sistermans E A, de Coo R F, van Beerendonk H M, et al.Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.Eur J Hum Genet, 2000, 8 (7) : 557-560.
  • 4Baslow M H. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. J Mol Neurosci,2000, 15 (2): 61-69.
  • 5Tahmaz F E, Sam S, Hoganson G E, et al. A partial deletion of the aspartoacylase gene is the cause of Canavan disease in a family from Mexico. J Med Genet, 2001, 38 (3) : E9.
  • 6Janson C, McPhee S, Bilaniuk L, et al. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther, 2002, 13(11) : 1391-1412.
  • 7Baslow M H. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int, 2002, 40(4): 295-300.
  • 8Coleman D L. Diabetes-obesity syndromes in mice. Diabetes,1982, 31 (suppl 1): 1-6.
  • 9Liu Z H, Li Y J, Chen Z H et al. Glucose transporter-1 in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein. Acta pharmacol Sin, 2001, 22 (2): 169-175.
  • 10Wurmbach E, Yuen T, Ebersole, et al. Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem,2001, 276 (50):47195-47201.

共引文献44

同被引文献32

  • 1Narurni S. Takeuchi T. Kobayashi Y. et al. Serum levels of IFN-inducible PROTEIN -10 relating to the activity of systemic lupus erythematosus[J]. Cytokine, 2000,12(10): 1561 -5.
  • 2Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV -coreceptor Bonzo [J]. Nat immunol, 2000,1 (4) : 298 - 304.
  • 3Wu T, Xie C, Wang H W, et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-L, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis [J]. J Immunol, 2007,179(10): 7166 -75.
  • 4Martini G, Cabrelle A, Calabrese F, et al. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis [J] . Clin Immunol, 2008,129(2): 268 -76.
  • 5Minami M, Kume N, Shimaoka T, et al. Expression of SRPSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions [J]. Arteri Thromb Vascular Biol, 2001 ,21 ( 11 ): 1796 - 800.
  • 6Singh S, Wu T, Xie C, et al. Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis [J]. Arthritis Res Ther, 2012,14(4): R164.
  • 7Teramoto K, Negoro N, Kitamoto K, et al. Microarray analysis of glomerular gene expression in murine lupus nephritis [J]. Pharmacol Sci, 2008 ,106 (1): 56 - 67.
  • 8Garcia G E, Truong L D, Li P, et al. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti -glomerular basement membrane antibody-associated glomerulonephritis [J]. Am J Pathol, 2007,170(5): 1485 -96.
  • 9Schramme A, Abdel- Bakky M S, Gutwein P, et al. Characterization of CXCL16 and ADAMlO in the normal and transplanted kidney[J]. Kidney Int, 200S, 74( 3) : 328 - 3S.
  • 10Lit L C, Wong C K, Tam L S, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus [J]. Ann Rheum Dis, 2006, 65 (2): 209 -15.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部